Modifiable Prognostic Factors of High Societal Costs in Musculoskeletal Disorders
Background
Musculoskeletal disorders create significant challenges for society. This study focuses on understanding factors that can be changed to reduce high societal costs for individuals on sick leave due to these disorders.
Methods
We analyzed data from a clinical trial involving 509 participants in Norway. The main goal was to see how certain factors relate to high societal costs, which include healthcare expenses and lost productivity. We used statistical methods to compare these factors with costs.
Results
Our findings showed that:
- A lower expectation of returning to work is linked to higher societal costs.
- Depressive symptoms and health literacy did not show a clear connection to costs.
- Results for pain severity, self-perceived health, sleep quality, work satisfaction, disability, and long-term disorder expectations were inconsistent.
Conclusion
This study confirmed that the expectation of returning to work is a significant factor in high societal costs for those on sick leave due to musculoskeletal disorders. Other factors were either not significant or showed mixed results.
Trial Registration
ClinicalTrials.gov NCT03871712, March 12, 2019.
Value of Clinical Trials
Clinical trials are essential for creating safe and effective treatments. To ensure these benefits reach everyday medical practice, we introduce DocSym, an AI-driven platform that integrates ICD-11 standards, clinical protocols, and research into one accessible resource for healthcare providers.
Practical Solutions
In today’s healthcare landscape, efficiency is vital. Our mobile apps facilitate:
- Scheduling appointments
- Monitoring treatments
- Telemedicine services
This makes managing patient care easier and enhances digital service delivery.
Improving Patient Outcomes
By leveraging AI, clinics can streamline workflows, improve patient outcomes, and reduce reliance on paper processes. Discover how we can assist you at aidevmd.com.
